Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.74 AUD 8.82% Market Closed
Market Cap: 255.2m AUD
Have any thoughts about
Aroa Biosurgery Ltd?
Write Note

Relative Value

The Relative Value of one ARX stock under the Base Case scenario is 1.74 AUD. Compared to the current market price of 0.74 AUD, Aroa Biosurgery Ltd is Undervalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARX Relative Value
Base Case
1.74 AUD
Undervaluation 58%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
61
vs Industry
72
Median 3Y
5.5
Median 5Y
4.5
Industry
7.6
Forward
3.3
vs History
vs Industry
Median 3Y
-34.9
Median 5Y
-37
Industry
22.1
Forward
505.7
vs History
vs Industry
Median 3Y
-39
Median 5Y
-47.4
Industry
21.9
vs History
vs Industry
Median 3Y
-18
Median 5Y
-20.1
Industry
23.4
vs History
61
vs Industry
37
Median 3Y
3
Median 5Y
3
Industry
2.5
vs History
58
vs Industry
63
Median 3Y
4.7
Median 5Y
4
Industry
7.5
Forward
3.1
vs History
58
vs Industry
62
Median 3Y
5.7
Median 5Y
4.7
Industry
9.3
vs History
vs Industry
Median 3Y
-31.6
Median 5Y
-36.4
Industry
4.2
Forward
63.1
vs History
vs Industry
Median 3Y
-31.6
Median 5Y
-36.4
Industry
4
Forward
-365.4
vs History
vs Industry
Median 3Y
-33.9
Median 5Y
-42.9
Industry
5.9
vs History
vs Industry
Median 3Y
-17.7
Median 5Y
-25.2
Industry
3.9
vs History
65
vs Industry
42
Median 3Y
4.2
Median 5Y
4.4
Industry
4.5

Multiples Across Competitors

ARX Competitors Multiples
Aroa Biosurgery Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Aroa Biosurgery Ltd
ASX:ARX
255.2m AUD 3.7 -37 -26.9 -26.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 134 846.2 -181 249.3 -220 094.3 -217 582.8
US
Abbvie Inc
NYSE:ABBV
318.1B USD 5.7 62.6 15.5 23.9
US
Amgen Inc
NASDAQ:AMGN
142.2B USD 4.4 33.6 16.1 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 4.1 929.1 10.3 10.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD 9.9 -219.3 21.6 22.7
US
Epizyme Inc
F:EPE
94.1B EUR 1 847.4 -471.4 -513.4 -499.7
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.7 32 19.8 24.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 5.7 16.9 15.4 17.1
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.6 -52.9
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.3 -135.8 -109.7 -79.9
P/S Multiple
Revenue Growth P/S to Growth
NZ
Aroa Biosurgery Ltd
ASX:ARX
Average P/S: 3 466 979.1
3.7
97%
0
FR
Pharnext SCA
OTC:PNEXF
38 134 846.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
34%
0.3
US
E
Epizyme Inc
F:EPE
1 847.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
NZ
Aroa Biosurgery Ltd
ASX:ARX
Average P/E: 214.8
Negative Multiple: -37
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 249.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62.6
413%
0.2
US
Amgen Inc
NASDAQ:AMGN
33.6
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
929.1
77%
12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -219.3
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -471.4 N/A N/A
AU
CSL Ltd
ASX:CSL
32
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NZ
Aroa Biosurgery Ltd
ASX:ARX
Average EV/EBITDA: 16.5
Negative Multiple: -26.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -220 094.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16.1
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.6
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -513.4 N/A N/A
AU
CSL Ltd
ASX:CSL
19.8
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NZ
Aroa Biosurgery Ltd
ASX:ARX
Average EV/EBIT: 21.5
Negative Multiple: -26.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 582.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.9
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.7
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -499.7 N/A N/A
AU
CSL Ltd
ASX:CSL
24.7
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -52.9 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.9 N/A N/A

See Also

Discover More
Back to Top